Skip to main content

Table 4 Counts for WBC subtypes at 6 months in the two groups

From: Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?

  RLDA (n = 27) MHDA (n = 37) p value
WBC (/μL) 5807.4 ± 1994.2 5465.0 ± 2006.1 0.501
% neutrophils 51.3 ± 12.0 62.8 ± 11.0 < 0.001
% eosinophils 2.8 ± 2.0 3.0 ± 2.9 0.881
% basophils 0.6 ± 0.4 0.4 ± 0.2 0.114
% monocytes 6.9 ± 2.6 5.8 ± 1.7 0.065
% lymphocytes 37.7 ± 11.3 26.7 ± 9.5 < 0.001
  1. The data are expressed as the mean ± standard deviation
  2. RLDA remission and low disease activity; MHDA moderate and high disease activity; WBC white blood cell
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us